Shop Apotheke Europe N.V., one of the leading online pharmacies in Continental Europe focused on non-prescription, over-the-counter (OTC) medication and pharmacy-related beauty and personal care (BPC) products, recently announced its Initial Public Offering (IPO) in Frankfurt.
The Company operates in Germany, Austria, France, Belgium, Spain, Italy and the Netherlands.
The offer consists of up to 3,571,428 newly issued shares from a capital increase of the company.
Additionally, investors may be allotted another 535,714 shares of a securities loan (Greenshoe shares) in the context of an over-allotment option.
The shares were offered to private and institutional investors from 29th September until approximately 11th October. The price range within which offers to purchase could be submitted is between EUR 28.00 and EUR 35.00.
According to Reuters, Shop Apotheke said in the statement: “The final number of newly issued shares was determined in a way that the Company will achieve gross proceeds of approximately 100 million (euros).”
The shares of Shop Apotheke Europe N.V. are expected to be traded on the regulated market and the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange.
Global law firm Hogan Lovells advised Shop Apotheke Europe N.V. on this IPO. In addition Avvocati Associati Franzosi Dal Negro Setti served as Legal Advisory to Shop Apotheke.
